Treatment Patterns by Race and Ethnicity in Newly Diagnosed Persons with Multiple Sclerosis.
Caroline Kelley GeigerDaniel SheinsonTu My ToDavid JonesNicole Gidaya BoninePublished in: Drugs - real world outcomes (2023)
Use of high-efficacy DMTs was low across all race/ethnicity subgroups of newly diagnosed pwMS in the US, including populations at a greater risk of experiencing rapid disease progression and severe disability.